AI-extracted claim
“Dr Prasad has held drug companies to different standards generating backlash from biotech and pharmaceutical industries”
Analyzed on 2026-09-18T18:42:55+00:00 · Last updated 2026-09-18
Plain language: Insufficient evidence was found to render a verdict.
Credibility score
out of 100
Based on 1 source
Low confidence
Original context
Show passage from source article
In recent months, Dr. Prasad has held drug companies to standards that were different from what they were expecting based on previous agency guidance, generating backlash from the biotech and pharmaceutical industries.
Extracted from: F.D.A. Refuses to Review Moderna Flu Vaccine , The New York Times
Evidence
This analysis is based on a single source. Confidence is low.
Bias distribution of supporting sources
Mean bias -0.20
Community Takes
No Takes have been written on this claim yet. Sign in to write a Take.